Interview with
Amarin Corporation plc (AMRN - NASDAQ)
Crystal Research Associates provides independent equity research coverage of Amarin Corporation plc (AMRN - NASDAQ), including a company snapshot, executive informational overview (EIO), and quarterly updates.
Amarin, headquartered in London, United Kingdom, is a neuroscience company focused on developing drugs to treat central nervous system (CNS) disorders.
Please visit the Research Coverage link below for greater details on Amarin Corporation, including the base reports and quarterly updates.